You can learn a lot about the future of healthcare by watching how a single pill gets made. From a small office in London, we sit down with Prof Alvaro Goyanes, co-founder and CEO of FabRx, to unpack how 3D printed pharmaceuticals are turning personalized medicine from an idea into a working system. If you’ve ever wondered why patients still get forced into a handful of standard doses, this conversation shows what changes when medicine becomes software-driven and printable on demand. We talk about what FabRx is building, why they’ve stayed deeply research-led while pushing toward clinical application, and how partnerships with hospitals are translating 3D printing into real studies. We also get specific about the compounding pharmacy workflow: “pharma ink” syringes prepared ahead of time, doses selected in software, and tablets printed with controls that reduce manual steps and help cut inconsistency. It’s a practical look at personalized drug manufacturing for therapies that need flexible dosing across pediatrics, elderly care, hormones, and more. Quality is the backbone of everything here, so we dig into traceability, weighing each unit, pressure-sensing to catch extrusion problems early, camera systems that verify prints, and where AI inspection and near-infrared methods fit in. We zoom out to the policy layer, including the UK’s move toward distributed point-of-care manufacturing and how regulators in Europe and the US are beginning to shape guidance for 3D printing in pharmacies. Then we end on a wild but serious frontier: why NASA cares about printing medicines in space, where supply chains and gravity don’t cooperate. If you care about personalized medicine, 3D printing in healthcare, and the future of compounding pharmacies, hit subscribe, share this with a friend in pharma or medtech, and leave a review telling us what application you want to see next.About Our Guest: Alvaro Goyanes is the co-founder and CEO of FABRX, the first company dedicated to developing 3D printing technology for the fabrication of personalized medicines and medical devices. He is also an Honorary Associate Professor at University College London- School of Pharmacy (UK) and an Associate Professor at the Faculty of Pharmacy, University of Santiago de Compostela (Spain).A pioneer in the field, Alvaro was among the first researchers to explore the potential of 3D printing for manufacturing oral dosage forms and medical devices. Recognized as a world expert in 3D-printed medicines, he has been listed among the World's Most Highly Influential Researchers by Web of Science for six consecutive years since 2019.Alvaro holds a PhD in Pharmaceutics from the University of Santiago de Compostela and previously worked as a Registered Pharmacist for three years, giving him firsthand insight into the needs of community pharmacy.Show notes: Coming soonSend us Fan MailSupport the showSubscribe to our premium version and support the show. Follow us: Twitter  Instagram Linkedin 3DHEALS WebsiteFacebookFacebook GroupYoutube channelAbout Pitch3D